Abstract
Endothelial dysfunction, a key process in development of cardiovascular diseases, is largely due to reduced nitric oxide (NO) derived from endothelial NO synthase (eNOS). Resveratrol has been reported to stimulate NO production via estrogen receptor α (ERα) activation in endothelial cells. Here, we investigated whether two natural methylated analogs of resveratrol, pterostilbene (Pts) and trans-3,5,4’-trimethoxystilbene (TMS), similarly to resveratrol, could influence endothelial NO release in human umbilical vein endothelial cells (HUVECs). In HUVECs exposed to Pts or TMS, NO production and phosphorylation of eNOS, protein kinase B (Akt), and ERα were measured by using a fluorimetric NO assay kit and Western blot analysis, respectively. Dimethylated Pts, but not trimethylated TMS, stimulated dose-dependent NO production via eNOS phosphorylation. Pts also stimulated dose-dependent phosphorylation of Akt, but not of ERα. NO production and eNOS phosphorylation in response to Pts were significantly abolished by the phosphoinositide 3-kinase (PI3K)/Akt inhibitor LY294002, but not by the ERα antagonist ICI182780. Our results suggest that Pts, but not TMS, is capable of inducing eNOS phosphorylation and the subsequent NO release, presumably, by activating PI3K/Akt pathway. The potential efficacy of Pts, an active constituent of blueberries, may aid in the prevention of cardiovascular diseases characterized by endothelial dysfunction.
Abbreviations
- Akt:
-
Protein kinase B
- DMSO:
-
Dimethyl sulfoxide
- eNOS:
-
Endothelial nitric oxide synthase
- ERα:
-
Estrogen receptor α
- HBSS:
-
Hank’s balanced salt solution
- HRP:
-
Horseradish peroxidase
- HUVECs:
-
Human umbilical vein endothelial cells
- L-NAME:
-
N G-Nitro-L-arginine methyl ester
- MTT:
-
3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide
- NO:
-
Nitric oxide
- PI3K:
-
Phosphoinositide 3-kinase
- Pts:
-
Pterostilbene
- TMS:
-
trans-3,5,4’-Trimethoxystilbene
References
Roupe KA, Remsberg CM, Yáñez JA, Davies NM (2006) Pharmacometrics of stilbenes: seguing towards the clinic. Curr Clin Pharmacol 1:81–101
Mikstacka R, Rimando AM, Ignatowicz E (2010) Antioxidant effect of trans-resveratrol, pterostilbene, quercetin and their combinations in human erythrocytes in vitro. Plant Foods Hum Nutr 65:57–63
Giovinazzo G, Ingrosso I, Paradiso A, De Gara L, Santino A (2012) Resveratrol biosynthesis: plant metabolic engineering for nutritional improvement of food. Plant Foods Hum Nutr 67:191–199
Vidavalur R, Otani H, Singal PK, Maulik N (2006) Significance of wine and resveratrol in cardiovascular disease: French paradox revisited. Exp Clin Cardiol 11:217–225
Kapetanovic IM, Muzzio M, Huang Z, Thompson TN, McCormick DL (2011) Pharmacokinetics, oral bioavailability, and metabolic profile of resveratrol and its dimethylether analog, pterostilbene, in rats. Cancer Chemother Pharmacol 68:593–601
Lin HS, Ho PC (2009) A rapid HPLC method for the quantification of 3,5,4’-trimethoxy-trans-stilbene (TMS) in rat plasma and its application in pharmacokinetic study. J Pharm Biomed Anal 49:387–392
Yamagata K, Tagami M, Yamori Y (2015) Dietary polyphenols regulate endothelial function and prevent cardiovascular disease. Nutrition 31:28–37
Hadi HA, Carr CS, Al Suwaidi J (2005) Endothelial dysfunction: cardiovascular risk factors, therapy, and outcome. Vasc Health Risk Manag 1:183–198
Piñeiro V, Ortiz-Moreno A, Mora-Escobedo R, Hernández-Navarro MD, Ceballos-Reyes G, Chamorro-Cevallos G (2010) Effect of L-arginine oral supplementation on response to myocardial infarction in hypercholesterolemic and hypertensive rats. Plant Foods Hum Nutr 65:31–37
Lorin J, Zeller M, Guilland JC, Cottin Y, Vergely C, Rochette L (2014) Arginine and nitric oxide synthase: regulatory mechanisms and cardiovascular aspects. Mol Nutr Food Res 58:101–116
Mount PF, Kemp BE, Power DA (2007) Regulation of endothelial and myocardial NO synthesis by multi-site eNOS phosphorylation. J Mol Cell Cardiol 42:271–279
Dimmeler S, Fleming I, Fisslthaler B, Hermann C, Busse R, Zeiher AM (1999) Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation. Nature 399:601–605
Heiss EH, Dirsch VM (2014) Regulation of eNOS enzyme activity by posttranslational modification. Curr Pharm Des 20:3503–3513
Klinge CM, Wickramasinghe NS, Ivanova MM, Dougherty SM (2008) Resveratrol stimulates nitric oxide production by increasing estrogen receptor alpha-Src-caveolin-1 interaction and phosphorylation in human umbilical vein endothelial cells. FASEB J 22:2185–2197
Liu D, Homan LL, Dillon JS (2004) Genistein acutely stimulates nitric oxide synthesis in vascular endothelial cells by a cyclic adenosine 5’-monophosphate-dependent mechanism. Endocrinology 145:5532–5539
Belleri M, Ribatti D, Nicoli S, Cotelli F, Forti L, Vannini V, Stivala LA, Presta M (2005) Antiangiogenic and vascular-targeting activity of the microtubule-destabilizing trans-resveratrol derivative 3,5,4’-trimethoxystilbene. Mol Pharmacol 67:1451–1459
Lorenz M, Wessler S, Follmann E, Michaelis W, Düsterhöft T, Baumann G, Stangl K, Stangl V (2004) A constituent of green tea, epigallocatechin-3-gallate, activates endothelial nitric oxide synthase by a phosphatidylinositol-3-OH-kinase-, cAMP-dependent protein kinase-, and Akt-dependent pathway and leads to endothelial-dependent vasorelaxation. J Biol Chem 279:6190–6195
Si H, Wyeth RP, Liu D (2014) The flavonoid luteolin induces nitric oxide production and arterial relaxation. Eur J Nutr 53:269–275
Edirisinghe I, Burton-Freeman B, Tissa Kappagoda C (2008) Mechanism of the endothelium-dependent relaxation evoked by a grape seed extract. Clin Sci (Lond) 114:331–337
Madeira SV, Auger C, Anselm E, Chataigneau M, Chataigneau T, Soares de Moura R, Schini-Kerth VB (2009) eNOS activation induced by a polyphenol-rich grape skin extract in porcine coronary arteries. J Vasc Res 46:406–416
Edirisinghe I, Banaszewski K, Cappozzo J, McCarthy D, Burton-Freeman BM (2011) Effect of black currant anthocyanins on the activation of endothelial nitric oxide synthase (eNOS) in vitro in human endothelial cells. J Agric Food Chem 59:8616–8624
Takizawa Y, Kosuge Y, Awaji H, Tamura E, Takai A, Yanai T, Yamamoto R, Kokame K, Miyata T, Nakata R, Inoue H (2013) Up-regulation of endothelial nitric oxide synthase (eNOS), silent mating type information regulation 2 homologue 1 (SIRT1) and autophagy-related genes by repeated treatments with resveratrol in human umbilical vein endothelial cells. Br J Nutr 110:2150–2155
Takahashi S, Nakashima Y (2012) Repeated and long-term treatment with physiological concentrations of resveratrol promotes NO production in vascular endothelial cells. Br J Nutr 107:774–780
Riche DM, Riche KD, Blackshear CT, McEwen CL, Sherman JJ, Wofford MR, Griswold ME (2014) Pterostilbene on metabolic parameters: a randomized, double-blind, and placebo-controlled trial. Evid Based Complement Alternat Med 2014:459165
Acknowledgments
This research was supported by the Bio & Medical Technology Development Program of the National Research Foundation (NRF) funded by the Korean government (MEST) (no. 2012M3A9C3048686).
Conflict of interest
The authors declare no conflicting interests or financial disclosures.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
ESM 1
(DOC 71 kb)
Rights and permissions
About this article
Cite this article
Park, S.H., Jeong, SO., Chung, HT. et al. Pterostilbene, an Active Constituent of Blueberries, Stimulates Nitric Oxide Production via Activation of Endothelial Nitric Oxide Synthase in Human Umbilical Vein Endothelial Cells. Plant Foods Hum Nutr 70, 263–268 (2015). https://doi.org/10.1007/s11130-015-0488-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11130-015-0488-3